Buscar
Mostrando ítems 1-10 de 15
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
(Dove Press Limited, 2016)
Both proprietary and nonproprietary medicines are expected to undergo rigorous preapproval testing and both should meet stringent health authority regulatory requirements related to quality to obtain approval. Nonproprietary ...
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
(Dove Press Limited, 2016)
Both proprietary and nonproprietary medicines are expected to undergo rigorous preapproval testing and both should meet stringent health authority regulatory requirements related to quality to obtain approval. Nonproprietary ...
Quality of artemisinin-based combination formulations for malaria treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria
(Public Library of Science, 2015-05)
Background Artemisinin-based combination therapies are recommended by the World Health Organisation (WHO) as first-line treatment for Plasmodium falciparum malaria, yet medication must be of good quality for efficacious ...
A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better
(American Society of Tropical Medicine and Hygiene, 2015-06)
In 2003, a stratified random sample survey was conducted in the Lao People's Democratic Republic (Laos) to study the availability and quality of antimalarials in the private sector. In 2012, this survey was repeated to ...
Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea
(BMJ Publishing Group, 2017-10)
Introduction Poor-quality artemisinin-containingantimalarials (ACAs), including falsified and substandardformulations, pose serious health concerns in malariaendemic countries. They can harm patients, contributeto the rise ...
Medicamentos falsificados y subestándar: un problema para la salud pública de Costa Rica y del mundo.
(2021)
La falsificación de medicamentos afecta a todos los países del mundo sin importar su ubicación geográfica o su grado de desarrollo económico. En Costa Rica, se han decomisado importantes cantidades de medicamentos y otros ...
Ambient mass spectrometry technologies for the detection of falsified drugs
(Royal Society of Chemistry, 2013-10)
Increased globalization of the pharmaceutical market has facilitated the unobstructed and fast spread of poor-quality medicines. Poor-quality medicines include spurious/falsely-labeled/falsified/counterfeit drugs (those ...
El problema de los medicamentos falsificados en el comercio electrónico colombiano: una aproximación desde el diseño legal
(Universidad de los AndesDerechoFacultad de Derecho, 2022-01-14)
Colombia y el mundo enfrentan uno de los problemas más difíciles de la salud pública en los últimos tiempos: la falsificación y adulteración de los medicamentos. La magnitud de sus efectos sobre la salud y economía de las ...
Estudio de bioequivalencia in vitro de cuatro productos de amoxicilina del mercado colombiano
(Revista Colombiana de Ciencias Químico Farmacéuticas, 2004)
Los estudios de bioequivalencia permiten demostrar si el principio activo tiene el mismo desempeño farmacocinético en el medicamento genérico que en el innovador, para así poderlos considerar intercambiables y garantizar ...